Human evolution has always captured our imagination, leading to discoveries that continuously reshape our understanding of our origins. Researchers at the University of Cambridge have made a significant breakthrough, revealing that all modern humans share DNA from two ancient populations. These
Ivan Kairatov is a Biopharma expert, with deep knowledge of tech and innovation in the industry and experience in research and development. He joins us today to discuss Ori Biotech’s new Preferred Partner Network (PPN), the collaboration with various organizations, and the impacts on cell therapy d
Alpha-1 antitrypsin deficiency (AATD) is a genetic disorder that significantly impacts both liver and lung function, resulting in a rare but severe health burden. In an ambitious and promising development, Prime Medicine is leveraging its innovative gene editing technology to address this
Resistant hypertension affects more than half of patients suffering from high blood pressure, presenting a significant challenge for healthcare providers. This condition often remains uncontrolled by multiple medications, typically linked to elevated levels of aldosterone, a hormone regulating
The question of whether Argo's proposed bioprocessing facility in Miami, Oklahoma, is safe for residents has sparked a significant amount of debate and concern within the community. This development has captured the attention of local residents who are apprehensive about potential
The integration of Artificial Intelligence (AI) in mammography screening has emerged as a promising approach to alleviate the workload pressures faced by radiologists while ensuring high standards of cancer detection accuracy. This study, originating from Denmark, delves into the potential benefits
Ivan Kairatov is a Biopharma expert with a wealth of knowledge in tech and innovation within the industry, bolstered by extensive experience in research and development. Today's interview will delve into the impact of recent administrative changes on VA hospitals, specifically examining the
Repligen, an innovative leader in bioprocess technology, has made a strategic move by acquiring essential upstream Process Analytical Technology (PAT) assets from 908 Devices for a total of $70 million. This acquisition should be viewed as more than just a simple addition of technology; it
Chloe Botaine engages Ivan Kairatov, a Biopharma expert with significant knowledge of tech and innovation within the industry, for a detailed discussion on the new AI-based system LILAC (Learning-based Inference of Longitudinal imAge Changes). Topics covered include the system's workings, its
The possibility of creating complex three-dimensional human tissues from diverse biological materials has always been an intriguing concept within medical research. The groundbreaking innovation known as the Electrospider, developed by Bio3DPrinting, a spinoff from Italy's University of Pisa,
